International experiences of promoting generics use and its implications to China
Author:
- 28 May 2013
- journal article
- brics
- Published by Wiley in Journal of Evidence-Based Medicine
- Vol. 6 (2) , 74-80
Abstract
Objective To summarize international experiences in promoting use of generics and to extract essence for China's reference. Method This is a commentary of two systematic reviews about policies to promote use of generics and its implications to China. Result Price, reimbursement, and generic substitution policies in European countries, and approaches in low and middle income countries in promoting market competition, appropriate intellectual property right protection strategy, and necessary demand side incentives, are all meaningful for China to contain soaring pharmaceutical expenditures, and to maintain the achievements and outcomes of the national health system reform. Conclusion Effective promotion of generics use must be practice based on the real situation. Tailor‐made and comprehensive measures are needed to address both demand and supply sides barriers before achieving tangible cost containment effect without unexpected side effects.Keywords
This publication has 4 references indexed in Scilit:
- The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overviewGenerics and Biosimilars Initiative Journal, 2012
- Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment ProgramsJAMA, 2010
- Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and ThailandAIDS, 2007
- Randomized, controlled trial of prescribing training in a South African provinceMedical Education, 2001